Table 2.
Key Comparison Measures | Pre-Intervention | Post-Intervention |
---|---|---|
Survey Period | 14–27 November 2019 | 17–31 August 2020 |
Number of antibiotic prescriptions | 231 | 73 |
Indications documented in EMR | 59% (n = 137) | 62% (n = 45) |
Indication entered in audit pop up tool | 41% (n = 94) | 38% (n = 28) |
Top three common indications | Skin and soft tissue infection (27%) | Skin and soft tissue infection (33%) |
Ear nose and throat 1 (23%) | Acute cystitis (22%) | |
Respiratory infection 2 (13%) | Respiratory infection 2 (12%) | |
Top three prescribed antibiotics | Amoxicillin (15%) | Amoxicillin-clavulanic acid (16%) |
Cefalexin (12%) | Cefalexin (15%) | |
Doxycycline (8%) | Trimethoprim (11%) |
1 Ear nose and throat includes acute otitis externa, acute otitis media, acute rhinosinusitis, pharyngitis and tonsillitis. 2 Respiratory tract infection includes infective exacerbation of asthma, bronchiectasis, bronchitis, influenza, pneumonia and upper respiratory tract infection not otherwise specified.